Mahindra Lifespace Q2FY27: PAT down 66% YoY to ₹16.3 Cr as JV profit contribution halves
PAT -65.9% YoY · revenue +84.6% · margins compressing
₹32.42 Cr
+84.6% YoY
₹16.34 Cr
-65.9% YoY
15.71%
-84.3pp YoY
₹0.77
Mahindra Lifespace's consolidated PAT for Q2 FY27 (quarter ended 30 September 2026) fell 65.9% year-on-year to ₹16.34 Cr from ₹47.91 Cr in Q2 FY26, even as revenue from operations — a small, lumpy line under the company's Completed Contracts Method of revenue recognition — rose 84.6% YoY to ₹32.42 Cr. Consolidated EPS was ₹0.77 versus ₹2.47 a year ago. No Q2 FY27-specific Street consensus was found in public previews (the result was announced same-day); the only available estimates are full-year FY27 figures (~₹1,000 Cr revenue, EPS ₹12.60, per Simply Wall St/consensus trackers, Buy-rated by all 7 covering analysts), which are not a reliable quarterly proxy given how unevenly this business books revenue. Management's standing FY27 guidance — ₹4,500-5,000 Cr residential presales and ₹10,000-20,000 Cr GDV addition, reaffirmed on the Q1 FY27 call — is not disclosed anywhere in this result filing, so it cannot be checked against this print; that verdict stays open until the concall/investor presentation.
Q2 FY-2027 vs prior quarters
The YoY decline is driven almost entirely by the Share of profit of joint ventures and associates line, which nearly halved to ₹42.89 Cr from ₹96.07 Cr a year ago — the real swing factor, since consolidated PBT itself was roughly flat YoY (₹49.50 Cr vs ₹50.74 Cr). That flatness masks a genuine improvement underneath: the core pre-JV segment (construction/development operations before associate profit) swung to a ₹6.61 Cr profit from a ₹45.33 Cr loss a year earlier, helped by total expenses easing to ₹97.41 Cr. But a ₹26.94 Cr gain sits inside this quarter's ₹71.60 Cr consolidated other income, booked on completing the divestment of the Ample Parks Group stakes for ₹76.52 Cr consideration. Stripping that one-off, underlying PBT falls to roughly ₹22.6 Cr and underlying PAT to an estimated ₹7-8 Cr (a precise net-of-tax isolation isn't possible from the disclosed tax lines) — implying an adjusted YoY PAT decline closer to ~84% rather than the reported 66%, a materially weaker underlying quarter than the headline suggests.
The stock went into the print at ₹334.6, down 7.1% over the past month of trading.
What the summary numbers don't show
Effective tax rate on consolidated PBT was unusually high at ~67% (tax ₹33.16 Cr on PBT ₹49.50 Cr).
FY27 residential presales ₹4,500-₹5,000 Cr (maintained). IC&IC ₹400-₹500 Cr annually with ₹1,500 Cr PAT over next few years. GDV addition ₹10,000-₹20,000 Cr (broadened from prior ₹10,000+ target). Pricing growth 4-6% (vs 7-8% historical).
Standalone results tell a very different story and should not be read as the group's performance: standalone PAT was ₹127.43 Cr (EPS ₹5.97) on other income of ₹231.40 Cr, mostly dividend income from subsidiaries/JVs (the cash-flow statement shows ₹209.15 Cr of H1 dividend income, concentrated in this quarter) that eliminates entirely on consolidation. Readers should anchor on the consolidated ₹16.34 Cr PAT.
W1
Whether Share of profit of JV/associates (₹42.89 Cr this quarter vs ₹96.07 Cr a year ago) stabilizes next quarter, since it currently drives consolidated PAT.
W2
FY27 presales guidance of ₹4,500-5,000 Cr and GDV addition of ₹10,000-20,000 Cr (maintained per Q1 FY27 concall) — not disclosed in this filing; confirm via the Q2 concall/presentation.
W3
Whether the ~67% effective tax rate on consolidated PBT normalizes in coming quarters.
Real estate developer using Completed Contracts Method (Ind AS 115) — company itself states quarterly results are not representative of steady operations. Standalone PAT (₹127.4 Cr) vastly exceeds consolidated PAT (₹16.3 Cr) because standalone other income (₹231.4 Cr) is dominated by intra-group dividends eliminated on consolidation; consolidated profit instead hinges on 'Share of profit of JV/associates' (₹42.9 Cr). Consolidated other income includes a ₹26.9 Cr one-off gain from the Ample Parks stake divestment (note 11). No formal 'Exceptional items' line was used in any of the three compared quarters. Effective consolidated tax rate (~67%) is unusually high given the small, volatile pretax base.
Can Mahindra Lifespace sustain Q1's momentum amid new-project ramp?
After a strong Q1 (PAT +67% YoY), MLDL enters Q2 with a bulging pipeline (₹3,500 Cr Pune launch, ₹1,500 Cr MMR redevelopment) and leadership transition. Street consensus is bullish—but execution on scale and margin hold are the real test.
The setup: post-Q1, can the story stay intact?
Mahindra Lifespace entered FY-2027 firing on all cylinders. Q1 delivered consolidated PAT of ₹85.6 Cr (EPS ₹4.01), up 67% year-on-year from ₹51.26 Cr. That wasn't a blip—the company swung its core operating profit to ₹102 Cr, signaling real operational traction. But here's the complication: Q2 typically faces monsoon-end demand headwinds, and MLDL is simultaneously ramping two major new launches (the ₹3,500 Cr Pune 'Rivenza' project and ₹1,500 Cr MMR redevelopment portfolio) while navigating a change at the helm. The Street is betting on the story anyway. What you want to watch is whether the margin and sales momentum hold through the scaling phase.
~₹75–90 Cr
On-plan assumption: some moderation from Q1's ₹85.6 Cr; still +40–60% YoY vs Q2 FY26.
Key watch
Q1 showed strong operating leverage. Test: does it persist as project ramps scale, or does onsite cost inflation bite?
Pune Rivenza unlock
Project launched Oct 6. Early traction in pre-sales and registrations will signal demand and execution quality.
₹4,500 Cr GDV
Pune (₹3,500 Cr) + MMR redevelopment societies (₹1,500 Cr). Sets up FY27–FY28 launches and revenue visibility.
What the Street sees (and the debate)
Since last quarter: the key moves
1 · Pune 'Rivenza' Launch (Oct 6)
₹3,500 Cr GDV residential project in Baner Annex, Mahalunge. RERA registered. Early sales momentum in the first 10 days will set the tone for Q2 pre-sales numbers.
2 · MMR Redevelopment Portfolio (Sep 30)
Added three societies (two in Borivali, one in Chembur) totaling ₹1,500 Cr GDV. Redevelopment cycle is long-tail, but signals landbank refresh and repeat landlord relationships.
3 · Management Transition (Aug 10)
Amit Kumar Sinha (MD & CEO) transitioning to lead Holidays & Lifespaces sector. Execution risk as new leadership beds in during a high-growth phase. Board meeting on Oct 22 to approve Q2 results.
4 · Associate Stake Sales (Aug 27)
Sold ₹80 Cr in associate stakes (Ample Parks entities). One-time item; check if this flows into consolidated P&L and how the company accounts for gains.
5 · Trading window closure (Oct 1–24)
Standard blackout before results. Oct 22 board meeting is the gate; quarterly P&L must show momentum retention.
On track? The trajectory test
The company is tracking its implicit full-year momentum, but with a caveat. Q1 FY27 was exceptional (PAT +67% YoY, EPS ₹4.01), riding a combination of project delivery cycles, cost discipline, and likely one-time gains. A strong Q2 would show: (1) PAT in the ₹80–95 Cr range, signaling momentum retention; (2) EBITDA margin stable or expanding as Pune ramp absorbs costs; (3) order-book updates showing pre-sales traction post-Rivenza launch. A weak Q2 would show: (1) PAT dip below ₹75 Cr, suggesting demand slowdown or margin compression; (2) EBITDA % slide as project costs accelerate; (3) muted pre-sales or order-book revision downward.
Mahindra Lifespace has the tailwinds (India residential cycle, ₹4,500 Cr pipeline), the momentum (Q1's 67% PAT growth), and Street conviction (consensus BUY, ₹491–500 target). But it's also at an inflection: ramping two major new projects, navigating a leadership transition, and facing the seasonal headwind of Q2 monsoons. On result day (Oct 22), focus on three things: (1) Can PAT hold ₹75–90 Cr range or does it crack below? (2) Do pre-sales and order-book numbers validate Pune Rivenza demand? (3) Are margins expanding or compressing as the company scales?